CASPIAN研究: Durvalumab联合化疗为广泛期小细胞肺癌患者带来总生存期获益

    Durvalumab Plus Platinum-Etoposide versus Platinum-Etoposide in First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer(CASPIAN): A Randomised, Controlled, Open-Label, Phase 3 Trial

    /

    返回文章
    返回